Signify Health, Inc.
If you purchased Signify Health, Inc. securities and would like to join the action, please click "Join This Action" below.
SGFY STOCK ALERT: HALPER SADEH LLP IS INVESTIGATING WHETHER THE SALE OF SIGNIFY HEALTH, INC. IS FAIR TO SHAREHOLDERS
September 5, 2022.
New York, New York—Halper Sadeh LLP, an investor rights law firm, is investigating whether the sale of Signify Health, Inc. (NYSE: SGFY) to CVS Health Corporation for $30.50 per share in cash is fair to Signify Health shareholders.
The investigation concerns whether Signify Health and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders by failing to, among other things: (1) obtain the best possible consideration for Signify Health shareholders; (2) determine whether CVS is underpaying for Signify Health; and (3) disclose all material information necessary for Signify Health shareholders to adequately assess and value the merger consideration. On behalf of Signify Health shareholders, Halper Sadeh LLP may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits.
Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.
Attorney Advertising. Prior results do not guarantee a similar outcome.